Literature DB >> 15085419

The risk of cardiovascular disease in adults who have had childhood nephrotic syndrome.

Brent Lee Lechner1, Detlef Bockenhauer, Sandra Iragorri, Thomas Lyle Kennedy, Norman Joseph Siegel.   

Abstract

While increased risk of cardiovascular disease (CVD) in patients with hyperlipidemia, chronic kidney disease (CKD), or end-stage renal disease (ESRD) is well documented, transient hyperlipidemia or intermittent renal disease as a consequence of relapsing nephrotic syndrome (NS) has not been studied. To investigate this enigma, 62 patients, between 25 and 53 years of age, who had steroid-responsive/dependent NS during childhood, were identified from the records of the Division of Pediatric Nephrology at Yale School of Medicine. Forty patients were located and contacted to ascertain symptoms or occurrences of CVD via a telephone interview. At the time of follow-up, 23-46 years after cessation of NS, none of these patients had ESRD or CKD. Three patients had experienced a myocardial infarction (MI): a 32-year-old male with a family history of CVD; a 41-year-old male with a history of heavy smoking, hypertension, diabetes mellitus, and elevated cholesterol; a 31-year-old male after a cocaine overdose. The occurrence of events (8%) and mortality from CVD (none) in this cohort of patients is comparable to patients of a similar age in the general population and is lower than that of patients of the same age who are on dialysis. The data suggest that relapsing NS during childhood does not place patients at increased risk for CVD mortality or morbidity compared with the general population. Consequently, it would appear that factors related to persistent proteinuria or renal insufficiency, rather than transient proteinuria and renal disease, contribute to the CVD documented in patients with CKD or ESRD.

Entities:  

Mesh:

Year:  2004        PMID: 15085419     DOI: 10.1007/s00467-004-1460-x

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  13 in total

Review 1.  Nephrotic syndrome: pathogenesis and management.

Authors:  Karl S Roth; Barbara H Amaker; James C M Chan
Journal:  Pediatr Rev       Date:  2002-07

2.  Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children.

Authors:  P Tarshish; J N Tobin; J Bernstein; C M Edelmann
Journal:  J Am Soc Nephrol       Date:  1997-05       Impact factor: 10.121

3.  Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children.

Authors:  M Abramowicz; H L Barnett; C M Edelmann; I Greifer; O Kobayashi; G C Arneil; B A Barron; G Gordillo-P; N Hallman; H A Tiddens
Journal:  Lancet       Date:  1970-05-09       Impact factor: 79.321

Review 4.  Dyslipidemia in pediatric renal disease: epidemiology, pathophysiology, and management.

Authors:  Jeffrey M Saland; Henry Ginsberg; Edward A Fisher
Journal:  Curr Opin Pediatr       Date:  2002-04       Impact factor: 2.856

Review 5.  Management of minimal lesion glomerulonephritis: evidence-based recommendations.

Authors:  J M Bargman
Journal:  Kidney Int Suppl       Date:  1999-06       Impact factor: 10.545

6.  Management of hyperlipidemia in children with refractory nephrotic syndrome: the effect of statin therapy.

Authors:  S A Sanjad; A al-Abbad; S al-Shorafa
Journal:  J Pediatr       Date:  1997-03       Impact factor: 4.406

7.  Possible induction of renal dysfunction in patients with lecithin:cholesterol acyltransferase deficiency by oxidized phosphatidylcholine in glomeruli.

Authors:  S Jimi; N Uesugi; K Saku; H Itabe; B Zhang; K Arakawa; S Takebayashi
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-03       Impact factor: 8.311

8.  Steroid-sensitive nephrotic syndrome: from childhood to adulthood.

Authors:  Fadi Fakhouri; Nathalie Bocquet; Pierre Taupin; Claire Presne; Marie-France Gagnadoux; Paul Landais; Philippe Lesavre; Dominique Chauveau; Bertrand Knebelmann; Michel Broyer; Jean-Pierre Grünfeld; Patrick Niaudet
Journal:  Am J Kidney Dis       Date:  2003-03       Impact factor: 8.860

9.  Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children.

Authors:  J Churg; R Habib; R H White
Journal:  Lancet       Date:  1970-06-20       Impact factor: 79.321

10.  Steroid-responsive nephrotic syndrome of childhood: a long-term study of clinical course, histopathology, efficacy of cyclophosphamide therapy, and effects on growth.

Authors:  J S Berns; K M Gaudio; L S Krassner; F P Anderson; D Durante; B M McDonald; N J Siegel
Journal:  Am J Kidney Dis       Date:  1987-02       Impact factor: 8.860

View more
  15 in total

1.  Blood concentration of aminothiols in children with relapse of nephrotic syndrome.

Authors:  Marcin Tkaczyk; Monika Miklaszewska; Jolanta Lukamowicz; Wojciech Fendler
Journal:  World J Pediatr       Date:  2016-06-29       Impact factor: 2.764

Review 2.  Dyslipidaemia in nephrotic syndrome: mechanisms and treatment.

Authors:  Shipra Agrawal; Joshua J Zaritsky; Alessia Fornoni; William E Smoyer
Journal:  Nat Rev Nephrol       Date:  2017-11-27       Impact factor: 28.314

3.  Homocysteine metabolism in children with idiopathic nephrotic syndrome.

Authors:  Mohan Kundal; Abhijeet Saha; N K Dubey; Kanika Kapoor; Trayambak Basak; Gaurav Bhardwaj; Vinay Singh Tanwar; Shantanu Sengupta; Vinita Batra; Ashish Dutt Upadhayay; Ajay Bhatt
Journal:  Clin Transl Sci       Date:  2014-01-23       Impact factor: 4.689

4.  Effect of atorvastatin on dyslipidemia and carotid intima-media thickness in children with refractory nephrotic syndrome: a randomized controlled trial.

Authors:  Pankaj Hari; Priyanka Khandelwal; Amit Satpathy; Smriti Hari; Ranjeet Thergaonkar; R Lakshmy; Aditi Sinha; Arvind Bagga
Journal:  Pediatr Nephrol       Date:  2018-08-08       Impact factor: 3.714

5.  Transient insulin-dependent diabetes mellitus in children with steroid-dependent idiopathic nephrotic syndrome during tacrolimus treatment.

Authors:  Katalin Dittrich; Ina Knerr; Wolfgang Rascher; Jörg Dötsch
Journal:  Pediatr Nephrol       Date:  2006-05-09       Impact factor: 3.714

6.  Different clinical outcomes for cardiovascular events and mortality in chronic kidney disease according to underlying renal disease: the Gonryo study.

Authors:  Masaaki Nakayama; Toshinobu Sato; Hiroshi Sato; Yuji Yamaguchi; Katsuya Obara; Isao Kurihara; Kazuto Sato; Osamu Hotta; Jin Seino; Masahiro Miyata; Kazuhisa Takeuchi; Kenji Nakayama; Masato Matsushima; Tetsuya Otaka; Yasumichi Kinoshita; Yoshio Taguma; Sadayoshi Ito
Journal:  Clin Exp Nephrol       Date:  2010-06-17       Impact factor: 2.801

Review 7.  The nephrotic syndrome: pathogenesis and treatment of edema formation and secondary complications.

Authors:  Melissa A Cadnapaphornchai; Oleksandra Tkachenko; Dmitry Shchekochikhin; Robert W Schrier
Journal:  Pediatr Nephrol       Date:  2013-08-30       Impact factor: 3.714

8.  Subclinical cardiovascular disease and its association with risk factors in children with steroid-resistant nephrotic syndrome.

Authors:  Cengiz Candan; Nur Canpolat; Selman Gökalp; Nurdan Yıldız; Pınar Turhan; Mehmet Taşdemir; Lale Sever; Salim Çalışkan
Journal:  Pediatr Nephrol       Date:  2013-09-15       Impact factor: 3.714

9.  Genetic variation of apolipoprotein E does not contribute to the lipid abnormalities secondary to childhood minimal change nephrotic syndrome.

Authors:  Peng Hu; Yuan Han Qin; Ling Lu; Bo Hu; Cheng Xue Jing; Feng Ying Lei; Ming Fang Li
Journal:  Int Urol Nephrol       Date:  2009-02-25       Impact factor: 2.370

10.  Complications of nephrotic syndrome.

Authors:  Se Jin Park; Jae Il Shin
Journal:  Korean J Pediatr       Date:  2011-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.